The pathogenesis and therapy of multiple sclerosis is based upon the requirement of a combination of myelin antigens for autoimmune demyelination
- 1 January 1982
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 2 (1) , 83-91
- https://doi.org/10.1016/0165-5728(82)90077-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cerebroside antibody titers in antisera capable of myelination inhibition and demyelinationBrain Research, 1978
- Encephalitogenic properties of purified preparations of bovine oligodendrocytes tested in guinea pigsBrain Research, 1978
- Cerebroside Antibody Inhibits Sulfatide Synthesis and Myelination and Demyelinates in Cord Tissue CulturesScience, 1974
- MYELINATION IN RAT BRAIN: CHANGES IN MYELIN COMPOSITION DURING BRAIN MATURATION1Journal of Neurochemistry, 1973
- Myelin Basic Protein Administration in Multiple SclerosisArchives of Neurology, 1973
- Multiple sclerosis: An immunologic reassessmentJournal of Chronic Diseases, 1973
- The immunogenesis of the multiple sclerosis plaqueBrain Research, 1971
- The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogenExperimental Neurology, 1968
- ENCEPHALITOGEN‐INDUCED INHIBITION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: PREVENTION, SUPPRESSION AND THERAPY*Annals of the New York Academy of Sciences, 1965
- THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITISThe Journal of Experimental Medicine, 1964